Skip to main content

Market Overview

Cardlytics Beats Q4 Revenue Estimates, Issues Cautious FY21 Guidance


Cardlytics Inc (NASDAQ: CDLXreported the fourth quarter of FY20  a revenue decline of 3.2% year-on-year to $67.1 million, beating analyst estimates of $60.89 million. 

  • Average FI MAUs (FI monthly active users) rose 22.6% to 163.6 million. ARPU (average revenue per user) declined 21.2% to $0.41.
  • Billings reduced 6.9% to $94 million, and contribution declined 4.4% to $29.7 million.
  • EBITDA declined 35% to $4.5 million. Net loss per share amounted to $0.05, missing the consensus estimate of $0.03 loss.
  • The company lost $7.6 million in operating cash flow.
  • Closing cash and cash equivalents were $293.22 million as of December 31, 2020.
  • The revenue outlook for the first quarter of FY21 lies between $47-53 million, close to the analyst estimate of $50.07 million. Billing estimates fall between $67-75 million. Contribution expectations lie between $20-24 million.
  • Additionally, Cardlytics acquired cash-back offers platform Dosh for $275M in a cash and stock deal.
  • Price action: CDLX stock closed lower by 0.33% at $132.43 on Friday.

Related Articles (CDLX)

View Comments and Join the Discussion!

Posted-In: Earnings News Guidance Tech Media

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at